Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...


Vicky joined Pappas Capital in 2023. Her background includes providing support in the fields of executive recruiting, software, municipal government, and insurance and investment services. Prior to joining Pappas Capital, Vicky worked with Focus Search Partners as a Project Coordinator.
Education:
Seattle Pacific University (BA, European Studies)